Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Plew Daniel P Van is EVP & General Mgr, Industrial at Regeneron Pharmaceuticals. OQRO lists 4 transactions filed with the SEC under this name, the latest on Dec 11, 2025, each linked to the official Form 4.
EVP & General Mgr, Industrial
Disclosures on record
4
Companies involved
1
Plew Daniel P Van has no open-market purchase on record since 2010. Sales in 12 of the 17 years since 2010.
Plew Daniel P Van reported 0 open-market purchases and 165 sales since 2010; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2024 | — | $9.83M13×13 trades |
| 2023 | — | $5.22M10×10 trades |
| 2022 | — | $22.3M45×45 trades |
| 2021 | — | $8.49M19×19 trades |
| 2020 | — | $46.1M30×30 trades |
| 2016 | — | $1.7M1×1 trade |
| 2015 | — | $18.6M17×17 trades |
| 2014 | — | $7.32M5×5 trades |
| 2013 | — | $10.9M13×13 trades |
| 2012 | — | $4.89M8×8 trades |
| 2011 | — | $881K2×2 trades |
| 2010 | — | $800K2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Regeneron PharmaceuticalsREGN
4 disclosures · Dec 2025
Dec 9, 20252,552disclosed Dec 11
DetailsOfficial recordDec 5, 20253,715disclosed Dec 9
DetailsOfficial recordDec 5, 202518Kdisclosed Dec 9
DetailsOfficial recordDec 8, 20251,906disclosed Dec 9
DetailsOfficial recordAs of the latest filing on , Plew Daniel P Van reported holding 21,673 shares of Regeneron Pharmaceuticals (REGN), worth about $20M at the last close of $923 (Nov 19, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Regeneron Pharmaceuticals REGN | 21,673 | 22K direct | $923 | $20M | Dec 9, 2025 |
Is this Plew Daniel P Van’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Dec 9, 2025, Plew Daniel P Van reported holding 21,673 shares of Regeneron Pharmaceuticals (REGN). At the last close of $923 on Nov 19, 2026, that is about $20M. This is the stake disclosed in filings, not a net worth.
No public filing gives Plew Daniel P Van's net worth. What SEC Form 4 shows is the stock stake: 21,673 shares of Regeneron Pharmaceuticals (REGN), about $20M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Plew Daniel P Van has no open-market purchase on record since 2010. Sales in 12 of the 17 years since 2010.
In SEC filings since 2010: no open-market purchase is on record; the latest open-market sale is from 2024.
Regeneron Pharmaceuticals (REGN), from 2010 to 2024: 0 purchases and 165 sales.
Plew Daniel P Van reported 0 open-market purchases and 165 sales here, 2010 to 2024.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.